Kucera R, Brown C L, Paulus H
J Cell Physiol. 1983 Nov;117(2):158-68. doi: 10.1002/jcp.1041170205.
Ribonucleoside diphosphate reductase (EC1.17.4.1) was previously characterized in exponentially growing mouse L cells selectively permeabilized to small molecules by treatment with dextran sulfate (Kucera and Paulus, 1982b). This characterization has now been extended to cells in specific phases of the cell cycle and in transition between cell cycle phases, with activity studied both in situ (permeabilized cells) and in cell extracts. Cells at various stages in the cell cycle were obtained by unit-gravity sedimentation employing a commercially available reorienting chamber device, by G1 arrest induced by isoleucine limitation, and by metaphase arrest induced by Colcemid. G1 cells from both cycling and noncycling populations had negligible levels of ribonucleotide reductase activity as measured by CDP reduction both in situ and in extracts. When G1 arrested cells were allowed to progress to S phase, ribonucleotide reductase activity increased in parallel with [3H]thymidine incorporation into DNA. Ribonucleotide reductase activity in extracts increased at a somewhat greater rate than in situ activity. S phase ribonucleotide reductase activity measured in situ resembled the previously characterized activity in exponentially growing cells with respect to an absolute dependence on ATP or its analogs as positive allosteric effector, sensitivity to the negative allosteric effector dATP, and low susceptibility to stimulation by NADPH, dithiothreitol, and FeCl3. Disruption of permeabilized cells caused reductase activity to become highly dependent on the presence of both dithiothreitol and FeCl3. As synchronized cultures progressed from S into G2/M phase, no significant change in ribonucleotide reductase activity was seen. On the other hand, when cells that had been arrested in metaphase by Colcemid were allowed to resume cell cycle traversal by removing the drug, in situ ribonucleotide reductase activity decreased by 75% within 2.5 h. This decrease seemed to be a late mitotic event, since it was not correlated with the percentage of cells entering G1 phase. The cause of a subsequent slight increase of in situ ribonucleotide reductase activity is not clear. Parallel measurements of ribonucleotide reductase activity in cell extracts indicated also an initial decline accompanied by increasing dependence on added dithiols and FeCl3, followed by complete activity loss. Our results suggest a cell cycle pattern of ribonucleotide reductase activity that involves negligible levels in G1 phase, a progressive increase of activity upon entry into S phase paralleling overall DNA synthesis, continued retention of significant ribonucleotide reductase activity well into the metaphase period of mitosis, and a very rapid decline in activity during the later phases of mitosis. The periods of increase and decrease of ribonucleotide reductase activity were accompanied by modulation of the properties of the enzyme as indicated by differential changes in enzyme activity measured in situ and in extracts.
核糖核苷二磷酸还原酶(EC1.17.4.1)先前已在通过硫酸葡聚糖处理对小分子具有选择性通透性的指数生长小鼠L细胞中得到表征(库切拉和保卢斯,1982b)。现在,这一表征已扩展至细胞周期特定阶段以及细胞周期阶段之间转换的细胞,同时研究了原位(通透细胞)和细胞提取物中的活性。通过使用市售的重新定向腔室装置进行单位重力沉降、异亮氨酸限制诱导的G1期停滞以及秋水仙酰胺诱导的中期停滞,获得了细胞周期不同阶段的细胞。通过原位和提取物中CDP还原测定,来自循环和非循环群体的G1期细胞的核糖核苷酸还原酶活性水平可忽略不计。当G1期停滞细胞进入S期时,核糖核苷酸还原酶活性与[3H]胸苷掺入DNA的过程同步增加。提取物中的核糖核苷酸还原酶活性增加速率比原位活性略快。原位测量的S期核糖核苷酸还原酶活性在对ATP或其类似物作为正构效应剂的绝对依赖性、对负构效应剂dATP的敏感性以及对NADPH、二硫苏糖醇和FeCl3刺激的低敏感性方面,类似于先前在指数生长细胞中表征的活性。通透细胞的破裂导致还原酶活性高度依赖于二硫苏糖醇和FeCl3的存在。随着同步培养物从S期进入G2/M期,核糖核苷酸还原酶活性未见明显变化。另一方面,当通过去除药物使被秋水仙酰胺阻滞在中期的细胞恢复细胞周期进程时,原位核糖核苷酸还原酶活性在2.5小时内下降了75%。这种下降似乎是有丝分裂后期事件,因为它与进入G1期的细胞百分比无关。原位核糖核苷酸还原酶活性随后轻微增加的原因尚不清楚。细胞提取物中核糖核苷酸还原酶活性的平行测量也表明最初有下降,同时对添加的二硫醇和FeCl3的依赖性增加,随后活性完全丧失。我们的结果表明,核糖核苷酸还原酶活性的细胞周期模式包括G1期活性可忽略不计,进入S期时活性逐渐增加并与总体DNA合成同步,在有丝分裂中期仍保持显著的核糖核苷酸还原酶活性,以及在有丝分裂后期活性迅速下降。核糖核苷酸还原酶活性增加和下降的时期伴随着酶性质的调节,这通过原位和提取物中测量的酶活性的差异变化得以体现。